1-15 of 616

Screening for Significant Fibrosis in Patients with Obesity
GI InsightsScreening for Significant Fibrosis in Patients with Obesity

Obesity and Liver Disease: Getting to the Core of Treatment
GI InsightsObesity and Liver Disease: Getting to the Core of Treatment

Is Lifestyle Intervention Enough for Obesity and MASLD?
GI InsightsIs Lifestyle Intervention Enough for Obesity and MASLD?

Treating Obesity Today: GLP-1s, Surgery, and Beyond
GI InsightsTreating Obesity Today: GLP-1s, Surgery, and Beyond

Maintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation
NutritionEdgeMaintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation
- advertisement

Personalized CRC Screening: Applying Real-World Evidence to Test Selection
Clinician's RoundtablePersonalized CRC Screening: Applying Real-World Evidence to Test Selection

Rethinking Who Qualifies for Advanced IBD Therapy
GI InsightsRethinking Who Qualifies for Advanced IBD Therapy

Aligning Medical and Patient Goals in IBD Treatment
GI InsightsAligning Medical and Patient Goals in IBD Treatment

ADHD Is Linked to a Broad Burden of GI Symptoms
NeuroFrontiersADHD Is Linked to a Broad Burden of GI Symptoms
- advertisement

Microbiome Signature May Help Predict Infliximab Response in Crohn’s Disease
GI InsightsMicrobiome Signature May Help Predict Infliximab Response in Crohn’s Disease

Diet-Microbiome Links Diverge in Crohn’s Disease and Ulcerative Colitis
GI InsightsDiet-Microbiome Links Diverge in Crohn’s Disease and Ulcerative Colitis

Closing Gaps in CRC Screening: From Stool-Based Testing to Timely Colonoscopy
Clinician's RoundtableClosing Gaps in CRC Screening: From Stool-Based Testing to Timely Colonoscopy




































